WASHINGTON, D.C. (Wednesday, December 01, 2010) - Media registration is now available online for the 13th Annual BIO CEO & Investor Conference – the largest independent investor conference focused on publicly-traded biotechnology companies. Hosted by the Biotechnology Industry Organization (BIO), the 13th annual event will take place at the Waldorf=Astoria in New York City. To register, please visit http://www.bio.org/bioceo/default.aspx?id=653.
The BIO CEO & Investor Conference will feature presentations from more than 130 emerging and established public biotech companies and non-profit funding organizations. The program will also include a number of therapeutic workshops featuring CSOs, MDs and industry analysts discussing new therapies and the latest areas of pipeline innovation in rheumatology, diagnostics, Endocrinology, neurology, and oncology.
Business Roundtables will focus on current investment trends and topics in biotechnology including financing, business development, licensing, M&A, clinical trial success rates, and reimbursement strategies. In addition, plenary session topics will include an Investor Perception of the Biotech Industry and a look at the health policy environment for 2011.
Attendees will have the opportunity to network with leading industry executives and investors, as well as utilize the BIO One-on-One Partnering system to set up investment meetings and make new contacts.
The BIO CEO & Investor Conference is a must attend event for institutional investors, industry analysts, and senior biotechnology executives focused on shaping the future investment landscape of the biotechnology industry.
To learn more about the BIO CEO & Investor Conference, including registration and up-to-date program information, please visit http://www.bio.org/bioceo/. Registration is complimentary for credentialed members of the media.
Upcoming BIO Events
Pacific Rim Summit on Industrial Biotechnology and Bioenergy
December 11-14, 2010
BIO Asia International Partnering Conference
January 24-25, 2011
BIO CEO & Investor Conference
February 14-15, 2011
New York, NY
BIO-Europe Spring 2011
March 14-16, 2011
BIO Intellectual Property Counsels Committee Spring Conference and Committee Meeting
April 13-15, 2011
BIO International Convention
June 27-30, 2011
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIO produces BIOtech Now, an online portal and monthly newsletter chronicling “innovations transforming our world.” Subscribe to BIOtech Now.
For more information:
Follow us on Twitter @IAmBiotech
Join us on LinkedIn/MyBio
Become a fan at facebook.com/IAmBiotech